Skip to main content
. Author manuscript; available in PMC: 2017 Dec 27.
Published in final edited form as: Nat Rev Dis Primers. 2015 Aug 27;1:15021. doi: 10.1038/nrdp.2015.21

Table 1.

Estimated global distribution of retinoblastoma.

Category Population, total Birth rate, crude (per 1,000 people) Mortality rate, infant (per 1,000 live births) Forecast live birth total Retinoblastoma incidence (high) 1:16,000 Retinoblastoma incidence (low) 1:18000 % of world retinoblastoma
World 7 × 109 19.4 34.6 131 106 8,200 7,300 100%
High income 1,299,489,520 11.6 5.5 14,941,320 934 830 11.4%
High income: non-OECD 249,927,994 13.8 10.3 3,418,872 214 190 not applicable
High income: OECD 1,049,561,526 11.0 4.4 11,518,845 720 640 not applicable
Low & middle income 5,743,616,071 21.1 38.1 116,699,203 7,294 6,483 88.7%
Middle income 4,913,580,797 19.2 33.7 91,300,546 5,706 5,072 69.4%
Upper middle income 2,390,210,774 14.8 16.3 34,737,317 2,171 1,930 26.4%
Lower middle income 2,523,370,023 23.4 45.3 56,490,388 3,531 3,138 42.9%
Low income 830,035,274 32.3 54.5 25,373,890 1,586 1,410 19.3%

Forecast births were calculated using most recent data (2012) on each World Bank Category for population, birth rate and mortality rate (World Bank (http://data.worldbank.org) accessed on 5 February 2015. Low (1:18,000 live births) and high estimates (1:16,000 live births) for retinoblastoma were calculated, following the example of Kivela.5 Since retinoblastoma arises before and near birth, the usual cancer incidence rate calculations (number of cases diagnosed in a given population, sometimes adjusted for the under-514 or under-1411 populations in children’s cancers) do not provide accurate data for retinoblastoma. OECD, Organisation for Economic Co-operation and Development

HHS Vulnerability Disclosure